
Loading, please wait...

Loading, please wait...

Ramaiah Memorial Hospital recently achieved a landmark by securing FACT accreditation India. Moreover, the Bengaluru-based facility now joins an elite group of global transplant centers. It is the only Indian hospital holding both FACT and Joint Commission International certifications. This dual recognition underscores the hospital's commitment to exceptional patient care and clinical safety.
Specialists regard FACT standards as the gold standard for hematopoietic stem cell transplantation. Consequently, these requirements ensure safety across the entire transplant ecosystem. The evaluation covers donor safety, clinical protocols, and long-term outcome reporting. Unlike general audits, this process focuses specifically on the complexities of cellular therapy. Therefore, this achievement marks a significant step forward for oncology and hematology standards in the country.
India currently faces a significant burden of hematologic disorders and blood cancers. Specifically, the country records over 120,000 new blood cancer cases every year. Additionally, many patients suffer from thalassemia, which requires bone marrow transplantation for a cure. Standardized programs are essential to improve the success rate of these procedures. Currently, the hospital evaluates nearly 1,000 patients with various blood disorders annually.
Academic mentorship from the University of Illinois helped the hospital align its protocols with international best practices. Furthermore, this partnership strengthens clinical confidence and standardizes treatment for complex cases. The accreditation also prepares the facility for advanced cellular therapies in the future. Thus, RMH continues to lead the way in improving healthcare quality within the region. This milestone ultimately benefits patients seeking curative treatments for severe blood diseases.
Q1: Why is FACT accreditation India significant for patients?
This accreditation ensures that a hospital follows the most rigorous global standards for safety and quality in cellular therapy. Consequently, it provides patients and donors with higher confidence in transplant outcomes and clinical protocols.
Q2: How does RMH distinguish itself from other transplant centers in India?
RMH is currently the only hospital in India to hold both FACT and JCI accreditations. This dual certification confirms that the facility meets international benchmarks for both general hospital infrastructure and specialized transplant care.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Ramaiah Memorial Hospital earns FACT accreditation for cellular therapy, becoming a leader in global quality standards for Indian bone marrow transplants....
8 months ago

Following Nigeria's first recorded Ebola case linked to regional travel, the Africa CDC has convened an emergency ministerial summit. This alert underscores critical clinical priorities for healthcare professionals, including differentiating early viral infection from malaria, implementing barrier nursing, and triage.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today